Ushbu ish iqtibos qilgan ishlar

81 ta ish

Ish: Synthetic lethality and DNA damage response targeting in cancer stem cells: a comprehensive review

Targeting cancer stem cells with CAR-based immunotherapy: biology, evidence, and future directions
Kaveh Hadiloo, Parsa Mostanadi, Ali Asadzadeh +2
Sharh maqola20256 iqtibos
ABI
Convergence of evolving artificial intelligence and machine learning techniques in precision oncology
Elena Fountzilas, Tillman Pearce, Mehmet A. Baysal +2
MaqolaOchiq kirish20255 iqtibos
ABI
CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy
Kaveh Hadiloo, Safa Tahmasebi, Abdolreza Esmaeilzadeh
Sharh maqola20235 iqtibos
ABI
Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance
Gh. Rasool Bhat, Itty Sethi, Hana Q. Sadida +14
Sharh maqola20245 iqtibos
ABI
Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy
Andras Heczey, Daofeng Liu, Gengwen Tian +10
Maqola20144 iqtibos
ABI
Diagnostic technologies for neuroblastoma
Leena Khelifa, Yubing Hu, Jennifer Tall +11
Sharh maqola20254 iqtibos
ABI
The multifaceted roles of PARP1 in DNA repair and chromatin remodelling
Arnab Ray Chaudhuri, André Nussenzweig
Sharh maqolaOchiq kirish20173 iqtibos
ABI
Functional Roles of CD133: More than Stemness Associated Factor Regulated by the Microenvironment
Ángela Patricia Moreno-Londoño, Martha Robles‐Flores
Sharh maqolaOchiq kirish20233 iqtibos
ABI
Intricate relationship between cancer stemness, metastasis, and drug resistance
Tikam Chand Dakal, Ravi Bhushan, Caiming Xu +7
Sharh maqola20243 iqtibos
ABI
Targeting colorectal cancer (stem-like) cells using LGR5 directed antibody drug conjugates
Daniela Hirsch, Thomas Ried
Boshqa20163 iqtibos
ABI
Targeting Cancer Stem Cells by Genetically Engineered Chimeric Antigen Receptor T Cells
Rowa Y. Alhabbab
Sharh maqola20203 iqtibos
ABI
Pre-conditioning modifies the TME to enhance solid tumor CAR T cell efficacy and endogenous protective immunity
John P. Murad, Dileshni Tilakawardane, Anthony K. Park +15
Maqola20213 iqtibos
ABI
CAR-T Cell Therapy for Breast Cancer: From Basic Research to Clinical Application
Yu-Huan Yang, Jiawei Liu, Lü Chen +1
Sharh maqola20223 iqtibos
ABI
Cancer cell targeting by CAR-T cells: A matter of stemness
Caterina D’Accardo, Gaetana Porcelli, Laura Rosa Mangiapane +10
Sharh maqola20223 iqtibos
ABI
Cancer Stem Cell Metabolism
Fidelia B. Alvina, Arvin M. Gouw, Anne Le
Maqola20213 iqtibos
ABI
Current strategies in cancer gene therapy
Anas El‐Aneed
Sharh maqola20042 iqtibos
ABI
DNA Damage Response in Cancer Therapy and Resistance: Challenges and Opportunities
Dana Jurkovičová, Christiana M. Neophytou, Ana Čipak Gašparović +1
Sharh maqola20222 iqtibos
ABI
Biomarkers and targeted therapy for cancer stem cells
Yusheng Liu, Hua Wang
Sharh maqola20232 iqtibos
ABI
Redirecting T Cells to Glypican-3 with 4-1BB Zeta Chimeric Antigen Receptors Results in Th1 Polarization and Potent Antitumor Activity
Wenpeng Li, Linjie Guo, Purva Rathi +8
Maqola20162 iqtibos
ABI
Epigenomic profiling of neuroblastoma cell lines
Kristen Upton, Apexa Modi, Khushbu Patel +10
Maqola20202 iqtibos
ABI
Molecular mechanisms of chemo‐ and radiotherapy resistance and the potential implications for cancer treatment
Yaping Liu, Can‐Can Zheng, Yun‐Na Huang +3
Sharh maqola20212 iqtibos
ABI
The CD44+/CD24-phenotype is enriched in basal-like breast tumors
Gabriella Honeth, Pär‐Ola Bendahl, Markus Ringnér +7
Maqola20082 iqtibos
ABI
DNA damage-inducing endogenous and exogenous factors and research progress
Nian Liu, Jiahui Du, Jing Ge +1
Sharh maqola20242 iqtibos
ABI
Regulation of Metabolic Plasticity in Cancer Stem Cells and Implications in Cancer Therapy
Styliani Papadaki, Angeliki Magklara
Sharh maqola20222 iqtibos
ABI
DNA Repair and Therapeutic Strategies in Cancer Stem Cells
Matthew S. Gillespie, Ciara Ward, Clare C. Davies
Sharh maqola20232 iqtibos
ABI